Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Baxter
Colorcon
Dow
McKesson

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

OXAYDO Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Oxaydo patents expire, and what generic alternatives are available?

Oxaydo is a drug marketed by Zyla and is included in one NDA. There are six patents protecting this drug.

This drug has thirteen patent family members in six countries.

The generic ingredient in OXAYDO is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.

Drug patent expirations by year for OXAYDO
Drug Prices for OXAYDO

See drug prices for OXAYDO

Recent Litigation for OXAYDO

Identify potential future generic entrants

District Court Litigation
Case NameDate
Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC2013-05-17
Purdue Pharma L.P. v. Impax Laboratories, Inc.2013-05-10
Acura Pharmaceuticals Inc. v. Ranbaxy Inc.2013-04-29

See all OXAYDO litigation

Pharmacology for OXAYDO
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Synonyms for OXAYDO
(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-1,2,3,4,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
4,5-Epoxy-14-hydroxy-3-methoxy-17-methyl-morphinan-6-one, hydrochloride, (5-alpha)- (9CI)
4,5alpha-Epoxy-14-hydroxy-3-methoxymorphinan-6-one Hydrochloride (Noroxycodone Hydrochloride)
52446-25-0
Dinarkon
Noroxycodone Hydrochloride
Noroxycodone Hydrochloride 1.0 mg/ml in Methanol (as free base)
Noroxycodone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Oxecta
Oxycodone hydrochloride [USAN:USP:JAN]
Oxycodone XR
Rexista

US Patents and Regulatory Information for OXAYDO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-001 Jun 17, 2011 RX No No   Start Trial   Start Trial Y   Start Trial
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-002 Jun 17, 2011 RX No No   Start Trial   Start Trial Y   Start Trial
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-001 Jun 17, 2011 RX No No   Start Trial   Start Trial Y   Start Trial
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-002 Jun 17, 2011 RX No No   Start Trial   Start Trial Y   Start Trial
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-002 Jun 17, 2011 RX No No   Start Trial   Start Trial Y   Start Trial
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-001 Jun 17, 2011 RX No No   Start Trial   Start Trial Y   Start Trial
Zyla OXAYDO oxycodone hydrochloride TABLET;ORAL 202080-001 Jun 17, 2011 RX No No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for OXAYDO

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1685839 92292 Luxembourg   Start Trial PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
Merck
Boehringer Ingelheim
Colorcon
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.